Brief: Mineralys Therapeutics Announces Pricing Of $175.0 Million Underwritten Public Offering Of Common Stock
12/03/2025 02:21
March 11 (Reuters) - Mineralys Therapeutics Inc MLYS.O: MINERALYS THERAPEUTICS ANNOUNCES PRICING OF $175.0 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK MINERALYS THERAPEUTICS INC - PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 12.96 MILLION SHARES OF COMMON STOCK AT $13.50 PER SHARE Source text: ID:nGNX8Grw5W Further company coverage: MLYS.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Mineralys Therapeutics
See all newsBrief: Mineralys Therapeutics Expands Its Board Of Directors With The Appointments Of Kristine Peterson And Lonnel Coats
Mineralys Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Medtronic, Macy's, USA Rare Earth
U.S. STOCKS ON THE MOVE-USA Rare Earth, MiniMed, Rent the Runway